Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202. (Q34495619)

25159623

2 August 2017

title

Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202. (English)

1 reference

2 August 2017

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

5

Paul E Sax

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

7

Ann C Collier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

6

Margaret Fischl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

4

Eric S Daar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Charles S Venuto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

Katie Mollan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

Kimberly Y Smith

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

Camlin Tierney

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

Gene D Morse

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

English

0 references

publication date

25 August 2014

1 reference

25159623

Journal of Antimicrobial Chemotherapy

2 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

3300-3310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine.

6 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Influence of alpha-1 glycoprotein acid concentrations and variants on atazanavir pharmacokinetics in HIV-infected patients included in the ANRS 107 trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Gender differences in the treatment of HIV infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Genetic, ethnic, and gender differences in the pharmacokinetics of antiretroviral agents

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Sex differences in pharmacokinetics and pharmacodynamics

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228779

Pharmacokinetics and pharmacodynamics of atazanavir-containing antiretroviral regimens, with or without ritonavir, in patients who are HIV-positive and treatment-naïve

6 July 2018

1 reference

Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection

21 January 2018

1 reference

A Population Pharmacokinetic-Pharmacogenetic Analysis of Atazanavir

21 January 2018

1 reference

The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors

21 January 2018

1 reference

Increasing participation of women in early phase clinical trials approved by the FDA.

21 January 2018

1 reference

Participation in research and access to experimental treatments by HIV-infected patients

21 January 2018

1 reference

Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application

21 January 2018

1 reference

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25159623

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of sex steroid hormones on gastric emptying and gastrointestinal transit in rats.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25159623

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25159623

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JAC/DKU303

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25159623 AND SRC:MED&resulttype=core&format=json

6 June 2020

25159623

1 reference